Join to view full profile
9500 Gilman DrLa Jolla, CA 92037
Dr. Yadlapati is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Gastroenterology, 2013 - 2016
New York Medical CollegeClass of 2009
Certifications & Licensure
CA State Medical License 2010 - 2028
CO State Medical License 2017 - 2021
IL State Medical License 2013 - 2017
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2017
- CMS Meaningful Use Stage 1 Certification Northwestern popHealth for Eligible Providers, Northwestern University, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
Publications & Presentations
PubMed
- Modern Diagnosis and Management of Acid-Related Disorders.Nicholas J Shaheen, Colin W Howden, Rena Yadlapati, Philip O Katz
Clinical Gastroenterology and Hepatology. 2026-10-01 - Diagnostic Accuracy of High-Resolution Manometry for Assessing Fundoplication Integrity: Validation of the Padova Classification.Arianna Vittori, Giovanni Capovilla, Matteo Santangelo, Rena Yadlapati, C Prakash Gyawali
Neurogastroenterology and Motility. 2026-10-01 - 1 citationsISOLATED LARYNGOPHARYNGEAL SYMPTOMS DO NOT PREDICT OBJECTIVE REFLUX EVIDENCE: AN INTERNATIONAL MULTICENTER VALIDATION STUDY OF THE SAN DIEGO CONSENSUS PATHWAY FOR SELE...Walter W Chan, Daniel Carmona-Guerrero, Francesca Forattini, Andrew Jenkins, Rahul Peravali
The American Journal of Gastroenterology. 2026-09-18
Authored Content
- A Preview of "Controversies in GERD Diagnosis & Management" at DDW 2024May 2024
Press Mentions
Phathom Pharmaceuticals to Highlight VOQUEZNA® (Vonoprazan) at the American College of Gastroenterology (ACG) 2025 Annual Scientific MeetingOctober 23rd, 2025- The Wild World Inside Your GutFebruary 22nd, 2023
- Study Pinpoints Best Predictor of When Reflux Symptoms Don't Require PPIJuly 6th, 2022
Grant Support
- The MVP Trial: A Randomized Controlled Trial of Mechanism Guided vs PPI Strategy for Laryngopharyngeal RefluxUNIVERSITY OF CALIFORNIA, SAN DIEGO2024–2029
- Mechanism Guided Therapy for Laryngopharyngeal RefluxUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
- Mechanism Guided Therapy for Laryngopharyngeal RefluxUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
- Role of Psychological Processes on Symptom Burden in Laryngopharyngeal RefluxUNIVERSITY OF CALIFORNIA, SAN DIEGO2023–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: